Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
1C), we chose the fasting condition for this study
GLP-1 analogues vary in their formulations, consisting of both - daily and weekly injections, as well as oral formulations
**In this video update:** Immediate pharma validation with 20,000 Pascal cassettes ordered for US drug trial Structured payment model: $150K upfront $650K regulatory milestones across FDA, IVDR, TGA Commercial timeline showing 20-year exclusivity and multiple revenue pathways **Why watch?** The test addresses drug-induced liver injury monitoring with substantively complete development
Abbreviations ARIC: Atherosclerosis Risk in Communities ASCVD: Atherosclerotic CVD CKD: Chronic kidney disease FG: Fasting glucose GLP-1: Glucagon-like peptide 1 SGLT-2: Sodiumglucose cotransporter 2 inhibitor References Centers for Disease Control and prevention (2024) National Diabetes Statistics Report
" For months these have been my daily go-to
